📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.2110557119

PubMed Identifier: 35442775

Publication URI: http://europepmc.org/abstract/MED/35442775

Type: Journal Article/Review

Volume: 119

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 17

ISSN: 0027-8424